Astal Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 157295,
    "name": "Astal Lab",
    "stock_name": "Astal Lab",
    "full_name": "Astal Laboratories Ltd",
    "name_url": "stocks-analysis/astal-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "71.24",
    "chg": -0.67,
    "chgp": "-0.93%",
    "dir": -1,
    "prev_price": "71.91",
    "mcapval": "313.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512600,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "sector_id": 79,
    "indexname": "India SENSEX",
    "isin": "INE307N01014",
    "curr_date": "Jun 08, 03:30 PM",
    "curr_time": "18:35 PM",
    "last_traded_at": "Jun 08, 03:30 PM IST",
    "bse_nse_vol": "17.55 k",
    "exc_status": "Active",
    "traded_date": "Jun 08, 2026",
    "traded_date_str": "2026 06 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astal-lab-157295-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Astal Laboratories Ltd Upgraded to Hold on Mixed Financial and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-upgraded-to-hold-on-mixed-financial-and-valuation-signals-4038163",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstalLaboratori_mojoScore_4038163.png",
        "date": "2026-06-08 08:07:21",
        "description": "Astal Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its financial quality, valuation attractiveness, and technical outlook despite a flat recent financial trend. This reassessment comes amid a mixed quarterly performance and evolving market dynamics, positioning the micro-cap stock as a cautious but watchful opportunity for investors."
      },
      {
        "title": "Astal Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4032644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstalLaboratori_valuationdot_4032644.png",
        "date": "2026-06-03 08:00:10",
        "description": "Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from a previously very expensive rating to a very attractive valuation grade. This change comes amid a backdrop of mixed returns and sector challenges, prompting investors to reassess the stock’s price attractiveness relative to its historical and peer benchmarks."
      },
      {
        "title": "Astal Laboratories Ltd Quality Upgrade Signals Improving Business Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-quality-upgrade-signals-improving-business-fundamentals-4032635",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstalLaboratori_qualitydot_4032635.png",
        "date": "2026-06-03 08:00:05",
        "description": "Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a notable upgrade in its quality grading from average to good, reflecting improvements in key business fundamentals. Despite this positive shift, the company’s stock performance remains under pressure, with a 4.58% decline on 3 June 2026 and a year-to-date return lagging behind the Sensex. This article analyses the underlying financial metrics driving the quality upgrade and assesses the implications for investors."
      },
      {
        "title": "Are Astal Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-astal-laboratories-ltd-latest-results-good-or-bad-4032336",
        "imagepath": "",
        "date": "2026-06-02 19:25:17",
        "description": "Astal Laboratories Ltd's latest financial results for the quarter ended March 2026 reflect a complex operational landscape. The company reported net sales of ₹134.05 crores, indicating a significant sequential growth of 156.60% from the previous quarter. However, year-on-year comparisons are less favorable, with net sales growth of 74.35% compared to 91.59% in the same quarter last year. \n\nNet profit for the March 2026 quarter was ₹7.68 crores, which represents a substantial increase of 225.42% from the preceding quarter. Yet, this figure is overshadowed by a year-on-year decline of 60.22%, highlighting challenges in maintaining profitability despite revenue growth. The profit after tax margin also saw a notable contraction, falling to 5.73% from 11.67% in the previous year, indicating that the rapid revenue expansion has come at the expense of profitability.\n\nOperating margins improved slightly to 7.60% fr..."
      },
      {
        "title": "Astal Laboratories Ltd Reports Flat Quarterly Financial Trend Amid Mixed Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-reports-flat-quarterly-financial-trend-amid-mixed-performance-4028921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstalLaboratori_fintrenddot_4028921.png",
        "date": "2026-06-02 08:00:04",
        "description": "Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has reported a flat financial performance for the quarter ended March 2026, signalling a notable shift from its previously positive growth trajectory. Despite a robust surge in net sales, the company’s profitability metrics have deteriorated sharply, prompting a downgrade in its Mojo Grade from Strong Sell to Sell as of 16 February 2026."
      },
      {
        "title": "Astal Laboratories Q4 FY26: Explosive Revenue Growth Masks Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/astal-laboratories-q4-fy26-explosive-revenue-growth-masks-profitability-concerns-4030831",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstalLaboratori_quaterlyResult_4030831.png",
        "date": "2026-06-01 21:30:35",
        "description": "Astal Laboratories Ltd., a micro-cap pharmaceutical intermediates and bulk drugs manufacturer, delivered a stunning 156.60% quarter-on-quarter revenue surge in Q4 FY26, yet the stock tumbled 3.24% to ₹71.46 on June 01, 2026, as investors grappled with sharply compressed margins and deteriorating profitability metrics. With a market capitalisation of ₹328.00 crores, the company's explosive topline expansion has failed to translate into bottom-line strength, raising critical questions about operational efficiency and sustainable growth."
      },
      {
        "title": "Are Astal Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-astal-laboratories-ltd-latest-results-good-or-bad-4023727",
        "imagepath": "",
        "date": "2026-05-30 19:40:00",
        "description": "Astal Laboratories Ltd's latest financial results for Q3 FY26 present a complex picture characterized by significant revenue growth alongside notable challenges in profitability. The company reported a remarkable year-on-year revenue increase of 261.27%, reaching ₹52.24 crores, which reflects strong market traction for its pharmaceutical intermediates and bulk drug offerings. This growth is particularly impressive when compared to the previous year's performance, where revenue growth was substantially lower at 71.94%.\n\nHowever, this explosive revenue growth is juxtaposed with a decline in net profit, which amounted to ₹2.36 crores, representing a year-on-year decrease of 5.22%. The operating margin has also faced considerable pressure, collapsing to 6.80% from 22.96% in the same quarter last year, indicating a significant erosion of profitability. This margin compression raises concerns about the sustainabi..."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-4016622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstalLaboratori_mojoScore_4016622.png",
        "date": "2026-05-27 10:10:04",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "When is the next results date for Astal Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-astal-laboratories-ltd-4015063",
        "imagepath": "",
        "date": "2026-05-26 23:18:03",
        "description": "The next results date for Astal Laboratories Ltd is scheduled for 30 May 2026...."
      }
    ],
    "total": 154,
    "sid": "157295",
    "stock_news_url": "https://www.marketsmojo.com/news/astal-laboratories-157295"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Jun-2026",
      "details": "Submission of newspaper publication for financial results for the quarter and year ended March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR) 2015- Authorization Of Kmps Under Regulation 30(5)",
      "datetime": "01-Jun-2026",
      "details": "Intimation of authorization of KMPs under regulation 30 (5) of SEBI (LODR) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR) 2015- Re-Appointment Of Internal Auditor.",
      "datetime": "31-May-2026",
      "details": "Internal Auditor appointment for the financial year 2026-27.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astal Laboratories Ltd Upgraded to Hold on Mixed Financial and Valuation Signals

2026-06-08 08:07:21

Astal Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its financial quality, valuation attractiveness, and technical outlook despite a flat recent financial trend. This reassessment comes amid a mixed quarterly performance and evolving market dynamics, positioning the micro-cap stock as a cautious but watchful opportunity for investors.

Read full news article

Astal Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-03 08:00:10

Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from a previously very expensive rating to a very attractive valuation grade. This change comes amid a backdrop of mixed returns and sector challenges, prompting investors to reassess the stock’s price attractiveness relative to its historical and peer benchmarks.

Read full news article

Astal Laboratories Ltd Quality Upgrade Signals Improving Business Fundamentals

2026-06-03 08:00:05

Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a notable upgrade in its quality grading from average to good, reflecting improvements in key business fundamentals. Despite this positive shift, the company’s stock performance remains under pressure, with a 4.58% decline on 3 June 2026 and a year-to-date return lagging behind the Sensex. This article analyses the underlying financial metrics driving the quality upgrade and assesses the implications for investors.

Read full news article

Are Astal Laboratories Ltd latest results good or bad?

2026-06-02 19:25:17

Astal Laboratories Ltd's latest financial results for the quarter ended March 2026 reflect a complex operational landscape. The company reported net sales of ₹134.05 crores, indicating a significant sequential growth of 156.60% from the previous quarter. However, year-on-year comparisons are less favorable, with net sales growth of 74.35% compared to 91.59% in the same quarter last year. Net profit for the March 2026 quarter was ₹7.68 crores, which represents a substantial increase of 225.42% from the preceding quarter. Yet, this figure is overshadowed by a year-on-year decline of 60.22%, highlighting challenges in maintaining profitability despite revenue growth. The profit after tax margin also saw a notable contraction, falling to 5.73% from 11.67% in the previous year, indicating that the rapid revenue expansion has come at the expense of profitability. Operating margins improved slightly to 7.60% fr...

Read full news article

Astal Laboratories Ltd Reports Flat Quarterly Financial Trend Amid Mixed Performance

2026-06-02 08:00:04

Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has reported a flat financial performance for the quarter ended March 2026, signalling a notable shift from its previously positive growth trajectory. Despite a robust surge in net sales, the company’s profitability metrics have deteriorated sharply, prompting a downgrade in its Mojo Grade from Strong Sell to Sell as of 16 February 2026.

Read full news article

Astal Laboratories Q4 FY26: Explosive Revenue Growth Masks Profitability Concerns

2026-06-01 21:30:35

Astal Laboratories Ltd., a micro-cap pharmaceutical intermediates and bulk drugs manufacturer, delivered a stunning 156.60% quarter-on-quarter revenue surge in Q4 FY26, yet the stock tumbled 3.24% to ₹71.46 on June 01, 2026, as investors grappled with sharply compressed margins and deteriorating profitability metrics. With a market capitalisation of ₹328.00 crores, the company's explosive topline expansion has failed to translate into bottom-line strength, raising critical questions about operational efficiency and sustainable growth.

Read full news article

Are Astal Laboratories Ltd latest results good or bad?

2026-05-30 19:40:00

Astal Laboratories Ltd's latest financial results for Q3 FY26 present a complex picture characterized by significant revenue growth alongside notable challenges in profitability. The company reported a remarkable year-on-year revenue increase of 261.27%, reaching ₹52.24 crores, which reflects strong market traction for its pharmaceutical intermediates and bulk drug offerings. This growth is particularly impressive when compared to the previous year's performance, where revenue growth was substantially lower at 71.94%. However, this explosive revenue growth is juxtaposed with a decline in net profit, which amounted to ₹2.36 crores, representing a year-on-year decrease of 5.22%. The operating margin has also faced considerable pressure, collapsing to 6.80% from 22.96% in the same quarter last year, indicating a significant erosion of profitability. This margin compression raises concerns about the sustainabi...

Read full news article

Astal Laboratories Ltd is Rated Sell

2026-05-27 10:10:04

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

When is the next results date for Astal Laboratories Ltd?

2026-05-26 23:18:03

The next results date for Astal Laboratories Ltd is scheduled for 30 May 2026....

Read full news article

View All News